Inventor · disambiguated record
Ross Stephens
Also filed as: STEPHENS III ROSS · STEPHENS ROSS · STEPHENS ROSS W · STEPHENS ROSS WENTWORTH
17 granted patents·5 pending applications·116 citations·filing 1994–2023
92Inventor score
Files withUNIV AUSTRALIAN NATIONAL5RIGSHOSPITALET3STEPHENS ROSS WENTWORTH3CANCERFORSKNINGSFONDET AF 19892BURCH WILLIAM MARTIN1
Top patents by PatentIndex Score
22 records- 0185US8061746B1Mango holderSTEPHENS III ROSS·Filed 2008·Granted Nov 22, 2011·17 cites·7 claims
- 0279US10232062B2Radiolabelled materialUNIV AUSTRALIAN NATIONAL·Filed 2013·Granted Mar 19, 2019·2 cites·17 claims
- 0376US9226939B2Histone inhibitionSTEPHENS ROSS WENTWORTH·Filed 2011·Granted Jan 5, 2016·4 cites·12 claims
- 0473US9381262B2Methods for radiolabeling synthetic polymersSTEPHENS ROSS WENTWORTH·Filed 2009·Granted Jul 5, 2016·4 cites·7 claims
- 0572US7807379B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2006·Granted Oct 5, 2010·3 cites·29 claims
- 0671US7108983B1Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2000·Granted Sep 19, 2006·11 cites·19 claims
- 0768US12295966B2Compounds for treating and preventing extracellular histone mediated pathologiesUNIV AUSTRALIAN NATIONAL·Filed 2023·Granted May 13, 2025·0 cites·12 claims
- 0863US2008171691A1Inhibition of invasive remodellingLUND LEIF ROGE·Filed 2008·Application pending·0 cites
- 0960US6248712B1Urokinase-type plasminogen activator receptorCANCERFORSKNINGSFONDET AF 1989·Filed 1995·Granted Jun 19, 2001·29 cites·28 claims
- 1059US5891664AVectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)CANCERFORSKNINGSFONDET AF 1989·Filed 1994·Granted Apr 6, 1999·23 cites·22 claims
- 1156US11628179B2Compounds for treating and preventing extracellular histone mediated pathologiesUNIV AUSTRALIAN NATIONAL·Filed 2018·Granted Apr 18, 2023·0 cites·11 claims
- 1256US2005137121A1Inhibition of invasive remodellingFiled 2004·Application pending·0 cites
- 1353US7026282B1Peptide antagonists of the human urokinase receptor and method for selecting themCANCERFORSKNINGSFONDEN AF 1989·Filed 1999·Granted Apr 11, 2006·22 cites·35 claims
- 1450US2011060529A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer markerRIGSHOSPITALET·Filed 2010·Application pending·0 cites
- 1549US2002099004A1Inhibition of invasive remodellingFiled 2001·Application pending·0 cites
- 1647US11896683B2Radiolabelled material for targeted administrationUNIV AUSTRALIAN NATIONAL·Filed 2017·Granted Feb 13, 2024·0 cites·19 claims
- 1746US9283291B2Methods for radiolabeling macromoleculesSTEPHENS ROSS WENTWORTH·Filed 2009·Granted Mar 15, 2016·0 cites·8 claims
- 1845US8778300B2Method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulateBURCH WILLIAM MARTIN·Filed 2006·Granted Jul 15, 2014·0 cites·12 claims
- 1945US7722856B2Process for the production of a radioactive aerosolCYCLOMEDICA AUSTRALIA PTY LTD·Filed 2006·Granted May 25, 2010·0 cites·21 claims
- 2044US12239650B2Compounds for treating and preventing net associated complicationsUNIV AUSTRALIAN NATIONAL·Filed 2019·Granted Mar 4, 2025·0 cites·6 claims
- 2139US2003027981A1Urokinase-type plasminogen activator receptorFiled 2001·Application pending·0 cites
- 2232US5962418AFactor VII-derived peptidesNYCOMED IMAGING AS·Filed 1994·Granted Oct 5, 1999·1 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →